Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-06-13 @ 7:17 PM
Study NCT ID:
NCT05754502
Status:
UNKNOWN
Last Update Posted:
2023-03-03
First Post:
2023-02-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy
Sponsor:
Consorzio Oncotech
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GIM26-TRASTHER
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |